Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.
Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.
protalix biotherapeutics股票下跌，公司公佈的Q2每股收益結果低於預期。
Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.
protalix biotherapeutics股票下跌，公司公佈的Q2每股收益結果低於預期。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。